Subcutaneous coimplantation experiments further demonstrated that LOXL2 knockdown suppressed the tumor-promoting effects of MMA-induced HPSCs (Fig. S7C–E) and reduced linear ECM alignment (Fig. S7J–L). This evidence concerns the gene LOXL2 and neoplasm.